Sulbactam-durlobactam: A Step Forward in Treating Carbapenem-Resistant <i>Acinetobacter baumannii</i> (CRAB) Infections
Richard Watkins, Robert A. Bonomo
Abstract
Antimicrobial resistance in gram-negative pathogens, such as Acinetobacter baumannii, is a serious threat to human health. Sulbactam-durlobactam, a unique β-lactam and a β-lactamase inhibitor combination, is a novel agent targeted against carbapenem-resistant A. baumannii. This supplement provides a summary of the development of SUL-DUR, discussing its unique features and role in treating infections caused by CRAB pathogens.
Topics & Concepts
Acinetobacter baumanniiSulbactamMedicineMicrobiologyAntimicrobialCarbapenemAcinetobacterAntibiotic resistanceAntibioticsBacteriaBiologyPseudomonas aeruginosaImipenemGeneticsAntibiotic Resistance in BacteriaAntibiotic Use and ResistanceAntibiotics Pharmacokinetics and Efficacy